Related Experiment Video
Updated: Aug 16, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
1Department of Medicine, Division of Hematology, Radiumhemmet, Karolinska Hospital, SE-171 76 Stockholm, Sweden.
Abstract:
The p53 tumor suppressor protein inhibits the formation of tumors through induction of cell cycle arrest and/or apoptosis. In the present study we demonstrated that p53 is also a powerful inhibitor of human telomerase reverse transcriptase (hTERT), a key component for telomerase. Activation of either exogenous temperature-sensitive (ts) p53 in BL41 Burkitt lymphoma cells or endogenous wild type (wt) p53 at a physiological level in MCF-7 breast carcinoma cells triggered a rapid downregulation of hTERT mRNA expression, independently of the induction of the p53 target gene p21. Co-transfection of an hTERT promoter construct with wt p53 but not mutant p53 in HeLa cells inhibited the hTERT promoter activity. Furthermore, the activation of the hTERT promoter in Drosophila Schneider SL2 cells was completely dependent on the ectopic expression of Sp1 and was abrogated by wt p53. Finally, wt p53 inhibited Sp1 binding to the hTERT proximal promoter by forming a p53-Sp1 complex. Since activation of telomerase, widely observed in human tumor cell lines and primary tumors, is a critical step in tumorigenesis, wt p53-triggered inhibition of hTERT/telomerase expression may reflect yet another mechanism of p53-mediated tumor suppression. Our findings provide new insights into both the biological function of p53 and the regulation of hTERT/telomerase expression.
Insights
The tumor suppressor p53 protein inhibits human telomerase reverse transcriptase (hTERT) expression. This discovery reveals a new mechanism for p53
Area of Science:
- Molecular Biology
- Cancer Research
- Tumor Suppressor Genes
Background:
- The p53 protein is a critical tumor suppressor involved in cell cycle arrest and apoptosis.
- Telomerase, particularly its key component human telomerase reverse transcriptase (hTERT), is frequently activated in human cancers, promoting tumorigenesis.
Purpose of the Study:
- To investigate the role of p53 in regulating human telomerase reverse transcriptase (hTERT) expression.
- To elucidate the molecular mechanisms by which p53 influences hTERT activity and its implications in tumor suppression.
Main Methods:
- Activation of exogenous temperature-sensitive p53 and endogenous wild-type p53 in human cancer cell lines (BL41, MCF-7).
- Analysis of hTERT mRNA expression and the p53 target gene p21.
- Reporter assays using an hTERT promoter construct in HeLa and Drosophila SL2 cells.
- Investigation of p53 and Sp1 interaction using co-transfection and binding assays.
Main Results:
- Activation of p53 led to rapid downregulation of hTERT mRNA expression, independent of p21.
- Wild-type p53 inhibited hTERT promoter activity in a dose-dependent manner.
- p53 abrogated Sp1-dependent activation of the hTERT promoter by forming a complex with Sp1, thereby inhibiting Sp1 binding.
Conclusions:
- Wild-type p53 directly inhibits hTERT expression and telomerase activity.
- p53-mediated inhibition of hTERT represents a novel mechanism of tumor suppression.
- These findings enhance understanding of p53's biological functions and hTERT/telomerase regulation in cancer.
Related Concept Videos
Negative Regulator Molecules
Telomeres and Telomerase
DNA Damage can Stall the Cell Cycle
Replicative Cell Senescence
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

